纤维化间质性肺病中的功能性衰老:衰弱对不良健康结局的影响
该前瞻性队列研究纳入540例纤维化间质性肺病患者(含100例IPF),以衰弱指数评估功能性衰老、以绝对端粒长度评估生物学年龄。结果显示衰弱指数与生活质量、住院率、住院时间及死亡率强相关,且可改善死亡率预后评估;而绝对端粒长度与多数不良结局无关。
要点
- 衰弱指数与纤维化间质性肺病患者的生活质量、住院率和死亡率强相关。
- 将衰弱指数加入常用临床参数可改善死亡率预后评估。
- 绝对端粒长度与多数不良健康结局无关。
核心结论
- 功能性衰老与纤维化间质性肺病患者的不良健康结局相关,提示临床决策中应考虑个体功能年龄。
研究设计与样本
- 前瞻性队列研究,从专科ILD门诊招募540例纤维化ILD患者,其中100例为IPF,共提供749次衰弱指数评估,189例提供血样。
- 以衰弱指数评估功能性衰老,以绝对端粒长度评估生物学年龄,采用多变量模型分析不良健康结局风险。
主要发现
- 衰弱指数与生活质量、住院率、出院时间和死亡率强相关,且校正年龄、性别、疾病严重程度和IPF诊断后仍显著。
- 将衰弱指数加入常用临床参数和既往验证的复合指数可改善死亡率预后评估。
- 绝对端粒长度与多数不良健康结局无关。
- chronological age对结局的影响主要由衰弱指数介导,绝对端粒长度介导程度较小。
临床怎么用
- 在纤维化间质性肺病患者的临床决策中应考虑个体功能年龄,可将衰弱指数用于预后评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accelerated biological and functional ageing is common in fibrotic interstitial lung disease (ILD); however, their impact on adverse health outcomes has not been evaluated in this population. METHODS: Patients were prospectively recruited from a specialised ILD clinic. Functional ageing was determined by frailty index and biological age by measurement of absolute telomere length (aTL) from patients' peripheral blood leukocytes. Adverse health outcomes included health-related quality of life (St George's Respiratory Questionnaire), number and length of respiratory and non-respiratory hospitalisations, medication tolerability and time to death or lung transplantation. Multivariable models were used to determine the risks and rates of adverse health outcomes associated with the frailty index and aTL. RESULTS: 540 patients with fibrotic ILD, including 100 with idiopathic pulmonary fibrosis (IPF), provided 749 frailty index assessments, with 189 patients providing blood samples. The frailty index was strongly associated with quality of life, rate of hospitalisation, time to hospital discharge and mortality, including adjustment for age, sex, disease severity and IPF diagnosis. Mortality prognostication was improved by the addition of the frailty index to commonly used clinical parameters and previously validated composite indices. Conversely, aTL was not associated with most adverse health outcomes. The effect of chronological age on outcomes was mediated primarily by the frailty index, and to a lesser extent by aTL. CONCLUSIONS: Functional ageing is associated with adverse health outcomes in patients with fibrotic ILD, indicating the need for consideration of the individual functional age into clinical decision-making.
引用
- Guler SA, Kwan JM, Leung JM, et al. Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes. Eur Respir J. 2020. PMID: 31537699. doi:10.1183/13993003.00647-2019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。